{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:07:49Z","timestamp":1791925669352,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271- TRR 205 (project B16)"],"award-info":[{"award-number":["314061271- TRR 205 (project B16)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KR-4371\/1-2"],"award-info":[{"award-number":["KR-4371\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KR-4371\/1-2"],"award-info":[{"award-number":["KR-4371\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271- TRR 205 (project B16)"],"award-info":[{"award-number":["314061271- TRR 205 (project B16)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271- TRR 205 (project B16)"],"award-info":[{"award-number":["314061271- TRR 205 (project B16)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KR-4371\/1-2"],"award-info":[{"award-number":["KR-4371\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271 - TRR205 project B16"],"award-info":[{"award-number":["314061271 - TRR205 project B16"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FA-466\/4-2"],"award-info":[{"award-number":["FA-466\/4-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Conditions of impaired adrenal function and tissue destruction, such as in Addison\u2019s disease, and treatment resistance of adrenocortical carcinoma (ACC) necessitate improved understanding of the pathophysiology of adrenal cell death. Due to relevant oxidative processes in the adrenal cortex, our study investigated the role of ferroptosis, an iron-dependent cell death mechanism and found high adrenocortical expression of glutathione peroxidase 4 (GPX4) and long-chain-fatty-acid CoA ligase 4 (ACSL4) genes, key factors in the initiation of ferroptosis. By applying MALDI mass spectrometry imaging to normal and neoplastic adrenocortical tissue, we detected high abundance of arachidonic and adrenic acid, two long chain polyunsaturated fatty acids which undergo peroxidation during ferroptosis. In three available adrenal cortex cell models (H295R, CU-ACC1 and CU-ACC-2) a high susceptibility to GPX4 inhibition with RSL3 was documented with EC<jats:sub>50<\/jats:sub> values of 5.7 \u00d7 10<jats:sup>\u22128<\/jats:sup>, 8.1 \u00d7 10<jats:sup>\u22127<\/jats:sup> and 2.1 \u00d7 10<jats:sup>\u22128<\/jats:sup>\u2009M, respectively, while all non-steroidogenic cells were significantly less sensitive. Complete block of GPX4 activity by RSL3 led to ferroptosis which was completely reversed in adrenal cortex cells by inhibition of steroidogenesis with ketoconazole but not by blocking the final step of cortisol synthesis with metyrapone. Mitotane, the only approved drug for ACC did not induce ferroptosis, despite strong induction of lipid peroxidation in ACC cells. Together, this report is the first to demonstrate extraordinary sensitivity of adrenal cortex cells to ferroptosis dependent on their active steroid synthetic pathways. Mitotane does not induce this form of cell death in ACC cells.<\/jats:p>","DOI":"10.1038\/s41419-020-2385-4","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T18:07:32Z","timestamp":1584468452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction"],"prefix":"10.1038","volume":"11","author":[{"given":"Isabel","family":"Weigand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"R\u00f6hrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura-Sophie","family":"Landwehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Urlaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Kendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Kiseljak-Vassiliades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"Wierman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Pedro Friedmann","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Walch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silviu","family":"Sbiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-6398","authenticated-orcid":false,"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-3161","authenticated-orcid":false,"given":"Matthias","family":"Kroiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"2385_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1055\/a-0804-2715","volume":"127","author":"A Barthel","year":"2019","unstructured":"Barthel, A. et al. An update on Addison\u2019s disease. Exp. Clin. Endocrinol. Diabetes 127, 165\u2013175 (2019).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"2385_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-12-111","volume":"12","author":"I Bronstad","year":"2011","unstructured":"Bronstad, I., Wolff, A. S., Lovas, K., Knappskog, P. M. & Husebye, E. S. Genome-wide copy number variation (CNV) in patients with autoimmune Addison\u2019s disease. BMC Med. Genet. 12, 111 (2011).","journal-title":"BMC Med. Genet."},{"key":"2385_CR3","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1210\/jc.2016-2368","volume":"101","author":"A Pazderska","year":"2016","unstructured":"Pazderska, A. et al. A variant in the BACH2 gene is associated with susceptibility to autoimmune addison\u2019s disease in humans. J. Clin. Endocrinol. Metab. 101, 3865\u20133869 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2385_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"Else, T. et al. Adrenocortical carcinoma. Endocr. Rev. 35, 282\u2013326 (2014).","journal-title":"Endocr. Rev."},{"key":"2385_CR5","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","volume":"179","author":"M Fassnacht","year":"2018","unstructured":"Fassnacht, M. et al. European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 179, G1\u2013G46 (2018).","journal-title":"Eur. J. Endocrinol."},{"key":"2385_CR6","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1210\/jc.2016-2894","volume":"102","author":"A Berruti","year":"2017","unstructured":"Berruti, A. et al. Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 102, 1358\u20131365 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2385_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1677\/erc.1.01029","volume":"12","author":"DE Schteingart","year":"2005","unstructured":"Schteingart, D. E. et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr. Relat. Cancer 12, 667\u2013680 (2005).","journal-title":"Endocr. Relat. Cancer"},{"key":"2385_CR8","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1210\/jc.2017-02591","volume":"103","author":"F Megerle","year":"2018","unstructured":"Megerle, F. et al. Mitotane monotherapy in patients with advanced adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 103, 1686\u20131695 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2385_CR9","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1634\/theoncologist.2016-0459","volume":"22","author":"DL Reidy-Lagunes","year":"2017","unstructured":"Reidy-Lagunes, D. L. et al. Complete responses to mitotane in metastatic adrenocortical carcinoma-a new look at an old drug. Oncologist 22, 1102\u20131106 (2017).","journal-title":"Oncologist"},{"key":"2385_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1470-2045(15)70081-1","volume":"16","author":"M Fassnacht","year":"2015","unstructured":"Fassnacht, M. et al. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. Lancet Oncol. 16, 426\u2013435 (2015).","journal-title":"Lancet Oncol."},{"issue":"09","key":"2385_CR11","first-page":"578","volume":"127","author":"Matthias Kroiss","year":"2018","unstructured":"Kroiss, M. et al. Treatment of refractory adrenocortical carcinoma with thalidomide: analysis of 27 patients from the European network for the study of adrenal tumours registry. Exp. Clin. Endocrinol. Diabetes 127, 578\u2013584 (2018).","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"key":"2385_CR12","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1530\/ERC-15-0452","volume":"23","author":"SG Creemers","year":"2016","unstructured":"Creemers, S. G. et al. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma. Endocr. Relat. Cancer 23, R43\u2013R69 (2016).","journal-title":"Endocr. Relat. Cancer"},{"key":"2385_CR13","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1210\/jc.2005-2639","volume":"91","author":"B Allolio","year":"2006","unstructured":"Allolio, B. & Fassnacht, M. Clinical review: adrenocortical carcinoma: clinical update. J. Clin. Endocrinol. Metab. 91, 2027\u20132037 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2385_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1530\/ERC-12-0368","volume":"20","author":"S Hescot","year":"2013","unstructured":"Hescot, S. et al. Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells. Endocr. Relat. Cancer 20, 371\u2013381 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"2385_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1530\/ERC-13-0150","volume":"20","author":"G Poli","year":"2013","unstructured":"Poli, G. et al. Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells. Endocr. Relat. Cancer 20, 537\u2013550 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"2385_CR16","doi-asserted-by":"publisher","first-page":"109924","DOI":"10.18632\/oncotarget.18968","volume":"8","author":"S Hescot","year":"2017","unstructured":"Hescot, S. et al. Identifying mitotane-induced mitochondria-associated membranes dysfunctions: metabolomic and lipidomic approaches. Oncotarget 8, 109924\u2013109940 (2017).","journal-title":"Oncotarget"},{"key":"2385_CR17","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1210\/en.2015-1367","volume":"156","author":"S Sbiera","year":"2015","unstructured":"Sbiera, S. et al. Mitotane inhibits sterol-O-acyl transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells. Endocrinology 156, 3895\u20133908 (2015).","journal-title":"Endocrinology"},{"key":"2385_CR18","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"2385_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41418-018-0193-5","volume":"26","author":"W Tonnus","year":"2019","unstructured":"Tonnus, W. et al. The clinical relevance of necroinflammation-highlighting the importance of acute kidney injury and the adrenal glands. Cell Death Differ. 26, 68\u201382 (2019).","journal-title":"Cell Death Differ."},{"key":"2385_CR20","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180\u20131191 (2014).","journal-title":"Nat. Cell Biol."},{"key":"2385_CR21","doi-asserted-by":"publisher","first-page":"16836","DOI":"10.1073\/pnas.1415518111","volume":"111","author":"A Linkermann","year":"2014","unstructured":"Linkermann, A. et al. Synchronized renal tubular cell death involves ferroptosis. Proc. Natl. Acad. Sci. USA 111, 16836\u201316841 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2385_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331 (2014).","journal-title":"Cell"},{"key":"2385_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0005-2760(82)90150-3","volume":"710","author":"F Ursini","year":"1982","unstructured":"Ursini, F., Maiorino, M., Valente, M., Ferri, L. & Gregolin, C. Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim. Biophys. Acta 710, 197\u2013211 (1982).","journal-title":"Biochim. Biophys. Acta"},{"key":"2385_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan, V. E. et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat. Chem. Biol. 13, 81\u201390 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"2385_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91\u201398 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"2385_CR26","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1038\/cdd.2017.149","volume":"24","author":"HO Fearnhead","year":"2017","unstructured":"Fearnhead, H. O., Vandenabeele, P. & Vanden Berghe, T. How do we fit ferroptosis in the family of regulated cell death? Cell Death Differ. 24, 1991\u20131998 (2017).","journal-title":"Cell Death Differ."},{"key":"2385_CR27","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1530\/JOE-13-0346","volume":"221","author":"R Prasad","year":"2014","unstructured":"Prasad, R., Kowalczyk, J. C., Meimaridou, E., Storr, H. L. & Metherell, L. A. Oxidative stress and adrenocortical insufficiency. J. Endocrinol. 221, R63\u2013R73 (2014).","journal-title":"J. Endocrinol."},{"key":"2385_CR28","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","volume":"15","author":"TJ Giordano","year":"2009","unstructured":"Giordano, T. J. et al. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin. Cancer Res. 15, 668\u2013676 (2009).","journal-title":"Clin. Cancer Res."},{"key":"2385_CR29","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1210\/en.2018-00064","volume":"159","author":"N Sun","year":"2018","unstructured":"Sun, N. et al. High-resolution tissue mass spectrometry imaging reveals a refined functional anatomy of the human adult adrenal gland. Endocrinology 159, 1511\u20131524 (2018).","journal-title":"Endocrinology"},{"key":"2385_CR30","first-page":"5488","volume":"50","author":"AF Gazdar","year":"1990","unstructured":"Gazdar, A. F. et al. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res. 50, 5488\u20135496 (1990).","journal-title":"Cancer Res."},{"key":"2385_CR31","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1530\/ERC-17-0447","volume":"25","author":"K Kiseljak-Vassiliades","year":"2018","unstructured":"Kiseljak-Vassiliades, K. et al. Development of new preclinical models to advance adrenocortical carcinoma research. Endocr. Relat. Cancer 25, 437\u2013451 (2018).","journal-title":"Endocr. Relat. Cancer"},{"key":"2385_CR32","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1172\/JCI110903","volume":"71","author":"DS Loose","year":"1983","unstructured":"Loose, D. S., Kan, P. B., Hirst, M. A., Marcus, R. A. & Feldman, D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J. Clin. Invest. 71, 1495\u20131499 (1983).","journal-title":"J. Clin. Invest."},{"key":"2385_CR33","doi-asserted-by":"publisher","first-page":"R263","DOI":"10.1530\/EJE-14-1014","volume":"172","author":"E Daniel","year":"2015","unstructured":"Daniel, E. & Newell-Price, J. D. Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing\u2019s syndrome. Eur. J. Endocrinol. 172, R263\u2013R280 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"2385_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/03602530600570040","volume":"38","author":"I Hanukoglu","year":"2006","unstructured":"Hanukoglu, I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab. Rev. 38, 171\u2013196 (2006).","journal-title":"Drug Metab. Rev."},{"key":"2385_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124582","volume":"10","author":"R Juhlen","year":"2015","unstructured":"Juhlen, R. et al. Role of ALADIN in human adrenocortical cells for oxidative stress response and steroidogenesis. PLoS ONE 10, e0124582 (2015).","journal-title":"PLoS ONE"},{"key":"2385_CR36","first-page":"R1484","volume":"268","author":"I Sarel","year":"1995","unstructured":"Sarel, I. & Widmaier, E. P. Stimulation of steroidogenesis in cultured rat adrenocortical cells by unsaturated fatty acids. Am. J. Physiol. 268, R1484\u2013R1490 (1995).","journal-title":"Am. J. Physiol."},{"key":"2385_CR37","doi-asserted-by":"crossref","first-page":"14118","DOI":"10.1016\/S0021-9258(18)66990-X","volume":"261","author":"Y Igarashi","year":"1986","unstructured":"Igarashi, Y. & Kimura, T. Adrenic acid content in rat adrenal mitochondrial phosphatidylethanolamine and its relation to ACTH-mediated stimulation of cholesterol side chain cleavage reaction. J. Biol. Chem. 261, 14118\u201314124 (1986).","journal-title":"J. Biol. Chem."},{"key":"2385_CR38","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1073\/pnas.94.7.2880","volume":"94","author":"MJ Kang","year":"1997","unstructured":"Kang, M. J. et al. A novel arachidonate-preferring acyl-CoA synthetase is present in steroidogenic cells of the rat adrenal, ovary, and testis. Proc. Natl. Acad. Sci. USA 94, 2880\u20132884 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2385_CR39","doi-asserted-by":"publisher","DOI":"10.4161\/23723556.2014.995047","volume":"2","author":"M Conrad","year":"2015","unstructured":"Conrad, M. & Friedmann Angeli, J. P. Glutathione peroxidase 4 (Gpx4) and ferroptosis: what\u2019s so special about it? Mol. Cell Oncol. 2, e995047 (2015).","journal-title":"Mol. Cell Oncol."},{"key":"2385_CR40","doi-asserted-by":"publisher","first-page":"22269","DOI":"10.1073\/pnas.1912700116","volume":"116","author":"A Belavgeni","year":"2019","unstructured":"Belavgeni, A. et al. Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis. Proc. Natl. Acad. Sci. USA 116, 22269\u201322274 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2385_CR41","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K. et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575, 688\u2013692 (2019).","journal-title":"Nature"},{"key":"2385_CR42","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll, S. et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693\u2013698 (2019).","journal-title":"Nature"},{"key":"2385_CR43","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/S0021-9258(17)35926-4","volume":"261","author":"S Bannai","year":"1986","unstructured":"Bannai, S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J. Biol. Chem. 261, 2256\u20132263 (1986).","journal-title":"J. Biol. Chem."},{"key":"2385_CR44","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.bbrc.2018.07.100","volume":"503","author":"D Wang","year":"2018","unstructured":"Wang, D., Xie, N., Gao, W., Kang, R. & Tang, D. The ferroptosis inducer erastin promotes proliferation and differentiation in human peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 503, 1689\u20131695 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2385_CR45","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao, J. Y. & Dixon, S. J. Mechanisms of ferroptosis. Cell Mol. Life Sci. 73, 2195\u20132209 (2016).","journal-title":"Cell Mol. Life Sci."},{"issue":"Suppl 2","key":"2385_CR46","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1007\/PL00014300","volume":"157","author":"JD Finkelstein","year":"1998","unstructured":"Finkelstein, J. D. The metabolism of homocysteine: pathways and regulation. Eur. J. Pediatr. 157(Suppl 2), S40\u2013S44 (1998).","journal-title":"Eur. J. Pediatr."},{"key":"2385_CR47","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41586-018-0360-3","volume":"560","author":"Z Hubler","year":"2018","unstructured":"Hubler, Z. et al. Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination. Nature 560, 372\u2013376 (2018).","journal-title":"Nature"},{"key":"2385_CR48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0009-2797(91)90085-L","volume":"79","author":"H Wiseman","year":"1991","unstructured":"Wiseman, H., Smith, C., Arnstein, H. R., Halliwell, B. & Cannon, M. The antioxidant action of ketoconazole and related azoles: comparison with tamoxifen and cholesterol. Chem. Biol. Interact. 79, 229\u2013243 (1991).","journal-title":"Chem. Biol. Interact."},{"key":"2385_CR49","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/j.1365-2133.2006.07655.x","volume":"156","author":"T Nakashima","year":"2007","unstructured":"Nakashima, T. et al. Inhibitory or scavenging action of ketoconazole and ciclopiroxolamine against reactive oxygen species released by primed inflammatory cells. Br. J. Dermatol. 156, 720\u2013727 (2007).","journal-title":"Br. J. Dermatol."},{"issue":"Suppl 3","key":"2385_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1046\/j.1365-2362.2000.0300s3076.x","volume":"30","author":"M Fassnacht","year":"2000","unstructured":"Fassnacht, M. et al. New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line. Eur. J. Clin. Invest. 30(Suppl 3), 76\u201382 (2000).","journal-title":"Eur. J. Clin. Invest."},{"key":"2385_CR51","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1021\/jm040202w","volume":"48","author":"VD Handratta","year":"2005","unstructured":"Handratta, V. D. et al. Novel C-17-heteroaryl steroidal CYP17 inhibitors\/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model. J. Med. Chem. 48, 2972\u20132984 (2005).","journal-title":"J. Med. Chem."},{"key":"2385_CR52","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1101\/gad.314674.118","volume":"32","author":"M Conrad","year":"2018","unstructured":"Conrad, M. et al. Regulation of lipid peroxidation and ferroptosis in diverse species. Genes Dev. 32, 602\u2013619 (2018).","journal-title":"Genes Dev."},{"key":"2385_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1416","volume":"10","author":"SJ Dixon","year":"2014","unstructured":"Dixon, S. J. & Stockwell, B. R. The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9\u201317 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"2385_CR54","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1021\/ar200024c","volume":"44","author":"DA Pratt","year":"2011","unstructured":"Pratt, D. A., Tallman, K. A. & Porter, N. A. Free radical oxidation of polyunsaturated lipids: new mechanistic insights and the development of peroxyl radical clocks. Acc. Chem. Res. 44, 458\u2013467 (2011).","journal-title":"Acc. Chem. Res."},{"key":"2385_CR55","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1021\/cr200246d","volume":"111","author":"JZ Haeggstrom","year":"2011","unstructured":"Haeggstrom, J. Z. & Funk, C. D. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem. Rev. 111, 5866\u20135898 (2011).","journal-title":"Chem. Rev."},{"key":"2385_CR56","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang, W. S. et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. USA 113, E4966\u2013E4975 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2385_CR57","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","volume":"3","author":"O Zilka","year":"2017","unstructured":"Zilka, O. et al. On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent. Sci. 3, 232\u2013243 (2017).","journal-title":"ACS Cent. Sci."},{"key":"2385_CR58","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1172\/JCI99032","volume":"128","author":"B Hassannia","year":"2018","unstructured":"Hassannia, B. et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J. Clin. Invest. 128, 3341\u20133355 (2018).","journal-title":"J. Clin. Invest."},{"key":"2385_CR59","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem. Biol. 26, 623\u2013633 e629 (2019).","journal-title":"Cell Chem. Biol."},{"key":"2385_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2006203","volume":"16","author":"H Feng","year":"2018","unstructured":"Feng, H. & Stockwell, B. R. Unsolved mysteries: how does lipid peroxidation cause ferroptosis? PLoS Biol. 16, e2006203 (2018).","journal-title":"PLoS Biol."},{"key":"2385_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1530\/EJE-18-0782","volume":"180","author":"S Schweitzer","year":"2019","unstructured":"Schweitzer, S. et al. Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma. Eur. J. Endocrinol. 180, 117\u2013125 (2019).","journal-title":"Eur. J. Endocrinol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2385-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2385-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2385-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:50:19Z","timestamp":1670251819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2385-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["2385"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2385-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"6 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"192"}}